Avidity Biosciences (RNA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec16

Pharmaceutical Industry M&A Value Up 31% in 2025 to $179.6 Billion

17:43

Nov24

Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement

22:11

Nov19

Avidity Biosciences Announces Management Access Program for DMD Patients

14:14

Nov14

FactSet analysts lower 2025 EPS forecast for Avidity Biosciences Inc

12:22

Nov11

RBC Capital analyst reiterates hold rating on Avidity Biosciences

12:32

Avidity Biosciences released FY2025 9 Months Earnings on November 10 (EST), with actual revenue of USD 17.9 M and EPS of USD -3.3836

04:00

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.847 M, Net Income -157.32 M, EPS -1.2136

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.573 M, Net Income -115.77 M, EPS -0.9

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change